Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study ‡
Titel:
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study ‡
Auteur:
Conte, P. Frassoldati, A. Bisagni, G. Brandes, A.A. Donadio, M. Garrone, O. Piacentini, F. Cavanna, L. Giotta, F. Aieta, M. Gebbia, V. Molino, A. Musolino, A. Ferro, A. Maltoni, R. Danese, S. Zamagni, C. Rimanti, A. Cagossi, K. Russo, A. Pronzato, P. Giovanardi, F. Moretti, G. Lombardo, L. Schirone, A. Beano, A. Amaducci, L. Bajardi, E.A. Vicini, R. Balduzzi, S. D’Amico, R. Guarneri, V.